Non Alcoholic Steatohepatitis (NASH)
Also known as: •Non-alcoholic Steatohepatitis (NASH) / NASH - Nonalcoholic Steatohepatitis / Non-Alcoholic Steato-Hepatitis (NASH) / Non-alcoholic Steatohepatitis NASH / NASH (Non-alcoholic Steato-hepatitis) / Nonalcoholic Steatohepatitis (NASH) / Non-Alcoholic Steatohepatitis(NASH) / NASH (Nonalcoholic Steatohepatitis) / NASH (Non-Alcoholic Steatohepatitis) / Non-Alcoholic Steatohepatitis (NASH) / Non Alcoholic Steato Hepatitis / Non-Alcoholic Steato-Hepatitis / Steatohepatitis, Nonalcoholic / Non-Alcoholic Steatohepatitis / Non Alcoholic Steatohepatitis / Nonalcoholic Steatohepatitis / Nonalcoholic steatohepatitis (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB09298 | Silibinin | A flavonolignan with hepatoprotective effects used to treat toxic liver damage and as an adjunct in the management of chronic conditions such as cirrhosis and hepatitis. |